Lou, E., Turner, S., Sumrall, A., Reardon, D. A., Desjardins, A., Peters, K. B., … Vredenburgh, J. J. (2011). Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma. J Clin Oncol, 29(28), e739–e742. https://doi.org/10.1200/JCO.2011.36.1865

Lou, Emil, Scott Turner, Ashley Sumrall, David A. Reardon, Annick Desjardins, Katherine B. Peters, John H. Sampson, Henry S. Friedman, and James J. Vredenburgh. “Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.” J Clin Oncol 29, no. 28 (October 1, 2011): e739–42. https://doi.org/10.1200/JCO.2011.36.1865.

Lou E, Turner S, Sumrall A, Reardon DA, Desjardins A, Peters KB, et al. Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma. J Clin Oncol. 2011 Oct 1;29(28):e739–42.

Lou, Emil, et al. “Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.” J Clin Oncol, vol. 29, no. 28, Oct. 2011, pp. e739–42. Pubmed, doi:10.1200/JCO.2011.36.1865.

Lou E, Turner S, Sumrall A, Reardon DA, Desjardins A, Peters KB, Sampson JH, Friedman HS, Vredenburgh JJ. Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma. J Clin Oncol. 2011 Oct 1;29(28):e739–e742.